A Phase I/II Placebo-Controlled Randomized Pilot Clinical Trial of Recombinant Deoxyribonuclease (DNase) Eye Drops Use in Patients With Dry Eye Disease

2019

Purpose To determine whether DNase eye drops have the potential to reduce signs and symptoms of dry eye disease (DED).

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

33

References

10

Citations